Genomic Health, Inc. (GHDX) Tops Q4 EPS by 3c, Guides FY13

February 6, 2013 5:11 PM EST Send to a Friend
Genomic Health, Inc. (NASDAQ: GHDX) reported Q4 EPS of $0.06, $0.03 better than the analyst estimate of $0.03. Revenue for the quarter came in at $60.4 million versus the consensus estimate of $58.9 million.

Genomic Health, Inc. sees FY2013 revenue of $258-266 million, versus the consensus of $262.40 million.

For earnings history and earnings-related data on Genomic Health, Inc. (GHDX) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment